| Date Initiated by Firm | June 08, 2004 |
| Date Posted | August 10, 2004 |
| Recall Status1 |
Terminated 3 on June 21, 2006 |
| Recall Number | Z-1333-04 |
| Recall Event ID |
29233 |
| Product Classification |
Oximeter - Product Code DQA
|
| Product | Welch Allyn Vital Signs Monitor 5300 Series 300
Part numbers 007-0098-00 through 007-0159-00 |
| Code Information |
Serial numbers JA000225 through JA002052. |
| FEI Number |
3023750
|
Recalling Firm/ Manufacturer |
Welch Allyn Protocol, Inc
8500 SW Creekside Pl
Beaverton
OR
97008-7107
|
| For Additional Information Contact | Marvin T. Iglehart 503-530-7909 |
Manufacturer Reason for Recall | Potential speaker failure could result in absence of audible annunciation of pulse tones, patient alarms and equipment alerts. |
FDA Determined Cause 2 | Other |
| Action | The firm contacted their customers and their distributors customers via letters dated June 8, 2004 through July 9, 2004. The letters instruct their customers to verify speaker functionality. If the customers do not hear two quick beeps or there is static then they have a faulty speaker. The letters instruct them to stop using the monitor and contact Welch Allyn to have the monitor repaired. If the monitor continues to emit two quick beeps their customers are to contact Welch Allyn to have the monitor repaired as soon as it is convenient. The customers are to verify the two beeps prior to each use. The letter dated June 8, 2004 went to only a couple of direct customers. The remaining letters dated June 14, 2004, June 23, 2004, June 30, 2004 and July 9, 2004 went to direct customers, distributors and distributors'' end user customers. |
| Quantity in Commerce | 1828 units |
| Distribution | Welch Allyn distributes product to hospitals, physicians and distributors nationwide and internationally. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
|